NOVASYS MEDICAL

$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional... , transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.

#People #Financial #Website #More

NOVASYS MEDICAL

Industry:

Developer Platform Health Care Medical

Founded:

1999-01-01

Address:

Newark, California, United States

Country:

United States

Website Url:

http://www.novasysmedical.com

Total Employee:

11+

Status:

Closed

Contact:

510-226-4060

Total Funding:

144.89 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF WordPress Apache Sitelinks Search Box Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins PHP

Founder

debra-reisenthel_image

Debra Reisenthel

Investors List

invesco-perpetual_image

Official Site Inspections

http://www.novasysmedical.com

Host Informations
Whois Informations

Loading ...